Alkylation of 3-phenyl-1H-pyrazolo[4,3-c] quinoline: Theoretical analysis of regioselectivity

Synthetic Communications

Volumn 37, Issue 8, 2007, Pages 1321-1330

  Savchenko, Timur I ^a   Silin, Olexiy V ^b   Kovalenko, Sergiy M ^b   Musatov, Vladymir I ^c   Nikitchenko, Viktor M ^a   Ivachtchenko, Alexander V ^d  

^a V N KARAZIN KHARKIV NATIONAL UNIVERSITY   (Ukraine)

^b Institute of Combinatorial Organic Chemistry   (Ukraine)

^c INSTITUTE FOR SINGLE CRYSTALS   (Ukraine)

^d CHEMDIV INC   (United States)

Author keywords

3 phenyl 1H pyrazolo 4.3 c quinoline; Alkylation; AM1 method; Regioselectivity

Indexed keywords

3 PHENYL 1H PYRAZOLO[4,3 C]QUINOLINE; 4 BROMOPHENACYL BROMIDE; ACETAMIDE DERIVATIVE; BENZYL CHLORIDE; METHYL IODIDE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CHEMICAL REACTION KINETICS; DRUG SYNTHESIS; STEREOCHEMISTRY; THEORETICAL STUDY;

EID: 34247144171     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910701227077     Document Type: Article

References (18)

1. (a) Palazzino, G.; Cecchi, L.; Melani, F.; Colotta, V.; Filacchioni, G.; Martini, C.; Lucacchini, A. 1,3-Diarylpyrazolo[4,5-c]-and -[5,4-c]quinolin-4-ones: Synthesis and specific inhibition of benzodiazepine receptor binding. J. Med. Chem. 1987, 30, 1737-42;
2. (b) Singh, P.; Ojha, T. N.; Sharma, R. C. Quantitative structure-activity relationship study on some ligands acting as inhibitors of benzodiazepine- receptor binding. Res. Commun. Chem. Pathol. Pharmacol 1990, 67, 151-4;
3. (c) Savini, L.; Chiasserini, L.; Pellerano, C.; Biggio, G.; Maciocco, E.; Serra, V.; Cinone, N.; Carrieri, A.; Altomare, C. A.; Carotti, A. High affinity central benzodiazepine receptor ligands, part 2: Quantitative structure-activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones. Bioorg. Med. Chem 2001, 9, 431-44.
4. Skotnicki, J.; Gilman, S. C.; Steinbaugh, B. A.; Musser, J. H US Patent 4748246, 1988.
5. Crespo, M. I.; Gracia, J.; Puig, C.; Vega, A.; Bou, J.; Beleta, J.; Domenech, T.; Ryder, H.; Segarra, V.; Palacios, J. M. Synthesis and biological evaluation of 2,5-dihydropyrazol. Bioorg. Med. Chem. Lett. 2000, 10, 2661-4.
6. Wentland, M. P US Patent 5334595, 1994; DerAbs. C94-248419.
7. (a) Suzuki, F.; Nakasato, Y.; Ohmori, K.; Tamura, T.; Hosoe, H.; Kubo, K.; Yoshitake, I. US Patent 5192768, 1993; Chem. Abstr. 1993 116(25) 255609m;
8. (b) Kinji, H.; Takahiro, T.; Makoto, I.; Toshiko, K.; Yukio, S.; Takuji, K JP Patent 5132484, 1993.
9. (a) Silin, O. V.; Savchenko, T. I.; Kovalenko, S. M.; Nikitchenko, V. M.; Ivachtchenko, A. V. Synthesis of 5H-Pyrazolo[4,3-c]quinolines. Heterocycles 2004, 63, 1883-90;
10. (b) Baumer, V. N.; Silin, O. V.; Savchenko, T. I.; Nikitchenko, V. M.; Kovalenko, S. M. 5-Benzyl-7,9-dimethoxy-3-phenyl-5H-pyrazolo[4,3-c]quinolin-1-ium chloride acetic acid solvate. Acta Cryst. 2004, E60, 294-96.
11. (a) Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. J. A new general purpose quantum mechanical molecular model. Am. Chem. Soc. 1985, 107, 3902-9;
12. (b) Dewar, M. J. S.; Dieter, K. M. J. Evaluation of AM1 calculated proton affinities and deprotonation enthalpies. Am. Chem. Soc. 1986, 108, 8075-86;
13. (c) Stewart, J. J. P. MOPAC - A semiempirical molecular orbital program. J. Comp. Aided Mol. Design 1990, 4, 1.
14. Izatt, R. M.; Pawlak, K.; Bradshaw, J. S.; Bruening, R. L. Thermodynamic and kinetic data for macrocycle interactions with cations and anions. Chem. Rev. 1991, 91, 1721-2085.
15. Furui, K. Modern Quantum Chemistry, Istanbul Lectures, Part 1; Sinanoglu, O., (Ed.); Academic Press: New York, 1965.
16. Ratcliffe, A. H.; Masek, B. B WO Patent 94/03453, 1994.
17. Ife, R. G.; Brown, T. H.; Leach, C. A. Chem. Abstr. 1988, 109, 073352v.
18. +-ATPase inhibitors. Bull. Korean Chem. Soc. 1998, 19, 667-669.